E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33%
Market Cap: 92.2B EUR
Have any thoughts about
Epizyme Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Epizyme Inc

Current Assets 186.8m
Cash & Short-Term Investments 144.4m
Receivables 11.2m
Other Current Assets 31.2m
Non-Current Assets 77.3m
PP&E 19.2m
Intangibles 40.8m
Other Non-Current Assets 17.4m
Current Liabilities 35m
Accounts Payable 5m
Accrued Liabilities 30m
Non-Current Liabilities 249.5m
Long-Term Debt 232.9m
Other Non-Current Liabilities 16.6m

Balance Sheet
Epizyme Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
98
124
190
208
78
227
87
140
168
98
Cash Equivalents
98
124
190
208
78
227
87
140
168
98
Short-Term Investments
0
0
0
0
164
50
154
242
205
78
Total Receivables
2
34
2
0
0
1
21
4
4
7
Accounts Receivables
2
34
2
0
0
0
20
3
3
7
Other Receivables
0
0
0
0
0
0
1
1
0
0
Inventory
0
0
0
0
0
0
0
0
11
3
Other Current Assets
1
2
3
5
7
9
12
15
18
19
Total Current Assets
101
160
195
213
249
286
273
399
405
206
PP&E Net
2
2
4
4
3
3
2
23
20
22
PP&E Gross
2
2
4
4
3
3
2
23
20
22
Accumulated Depreciation
2
3
3
5
6
7
8
8
7
8
Intangible Assets
0
0
0
0
0
0
0
0
47
43
Other Long-Term Assets
1
1
1
1
1
1
1
2
2
19
Total Assets
104
N/A
163
+57%
199
+22%
218
+9%
252
+16%
289
+15%
276
-5%
425
+54%
474
+12%
289
-39%
Liabilities
Accounts Payable
3
5
8
5
5
7
5
9
10
10
Accrued Liabilities
4
7
7
11
16
18
20
26
33
35
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
1
1
0
0
0
0
0
Other Current Liabilities
28
23
2
2
0
0
13
0
0
0
Total Current Liabilities
36
35
17
18
22
25
38
34
43
45
Long-Term Debt
0
0
0
1
0
0
0
36
230
232
Other Liabilities
43
24
22
29
29
29
5
23
15
32
Total Liabilities
79
N/A
59
-25%
39
-34%
48
+24%
51
+5%
54
+7%
43
-21%
94
+120%
289
+209%
310
+7%
Equity
Common Stock
76
0
0
0
0
0
0
37
36
36
Retained Earnings
53
56
111
244
354
488
587
757
989
1 240
Additional Paid In Capital
2
160
271
413
556
724
820
1 051
1 138
1 183
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
25
N/A
104
+317%
160
+54%
170
+6%
202
+19%
235
+17%
233
-1%
331
+42%
185
-44%
21
N/A
Total Liabilities & Equity
104
N/A
163
+57%
199
+22%
218
+9%
252
+16%
289
+15%
276
-5%
425
+54%
474
+12%
289
-39%
Shares Outstanding
Common Shares Outstanding
2
29
34
42
58
69
79
98
102
106
Preferred Shares Outstanding
62
0
0
0
0
0
0
0
0
0

See Also

Discover More